B. Hasemeier

发表

Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer

U. Lehmann, H. Kreipe, M. Müller, 2008, The Journal of pathology.

The CpG island methylator phenotype in breast cancer is associated with the lobular subtype.

D. Steinemann, R. Geffers, R. Schmutzler, 2015, Epigenomics.

Quantitative Analysis of Promoter Hypermethylation in Laser-Microdissected Archival Specimens

U. Lehmann, H. Kreipe, R. Lilischkis, 2001, Laboratory Investigation.

Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype.

U. Lehmann, H. Kreipe, F. Länger, 2002, Cancer research.

Amplified expression, purification and functional reconstitution of the dipeptide and tripeptide transport protein of Lactococcus lactis.

A. Hagting, B. Poolman, W. N. Konings, 1997, European journal of biochemistry.

Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technology

R. Geffers, U. Lehmann, H. Kreipe, 2013, Haematologica.

Feasibility of combined detection of gene mutations and fusion transcripts in bone marrow trephines from leukemic neoplasms.

U. Lehmann, H. Kreipe, G. Büsche, 2020, The Journal of molecular diagnostics : JMD.

Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma

T. Krech, U. Lehmann, H. Kreipe, 2014, The Journal of pathology.

Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes *

U. Lehmann, H. Kreipe, F. Länger, 2010, European journal of haematology.

[Methylation status of LINE-1 sequences in patients with MDS or secondary AML].

U. Lehmann, H. Kreipe, F. Länger, 2007, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

Comprehensive genetic and functional characterization of IPH‐926: a novel CDH1‐null tumour cell line from human lobular breast cancer

D. Steinemann, M. Ballmaier, T. Krech, 2009, The Journal of pathology.

Quantitative assessment of promoter hypermethylation during breast cancer development.

U. Lehmann, H. Kreipe, F. Länger, 2002, The American journal of pathology.

Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection.

U. Lehmann, H. Kreipe, B. Hasemeier, 2017, The Journal of molecular diagnostics : JMD.

Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker

T. Krech, U. Lehmann, H. Kreipe, 2013, International journal of cancer.

Identification of differentially expressed microRNAs in human male breast cancer

Thomas Streichert, Ulrich Lehmann, Benjamin Otto, 2010, BMC Cancer.

Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology

U. Lehmann, H. Kreipe, B. Hasemeier, 2008, BMC biotechnology.

Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution

U. Lehmann, H. Kreipe, S. Suerbaum, 2011, BMC biotechnology.

Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc.

O. Ammerpohl, U. Lehmann, H. Kreipe, 2012, BMC Research Notes.

Global increase in DNA methylation in patients with myelodysplastic syndrome

U. Lehmann, H. Kreipe, F. Länger, 2008, Leukemia.

primary myelofibrosis SRSF2 mutation is present in the hypercellular and prefibrotic stage of

R. Geffers, U. Lehmann, H. Kreipe, 2013 .

Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival

T. Krech, U. Lehmann, H. Kreipe, 2015, Clinical Epigenetics.

Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma

T. Krech, U. Lehmann, H. Kreipe, 2012, PloS one.

LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype

U. Lehmann, H. Kreipe, S. Anwar, 2019, PloS one.

Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis.

A. Heim, U. Lehmann, H. Kreipe, 2007, Human molecular genetics.

SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis.

R. Geffers, U. Lehmann, H. Kreipe, 2013, Blood.

hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma

T. Krech, U. Lehmann, H. Kreipe, 2017, World journal of gastroenterology.

Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms

U. Lehmann, H. Kreipe, B. Hasemeier, 2016, Oncotarget.

Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis

U. Lehmann, H. Kreipe, G. Büsche, 2019, Leukemia.

Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc.

O. Ammerpohl, U. Lehmann, H. Kreipe, 2012, BMC Research Notes.

Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.

A. Seltsam, M. Tessema, U. Lehmann, 2005, International journal of oncology.

Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival

T. Krech, U. Lehmann, H. Kreipe, 2015, Clinical Epigenetics.

Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker

T. Krech, U. Lehmann, H. Kreipe, 2013, International journal of cancer.

[Epigenetic inactivation of microRNA genes in mammary carcinoma].

U Lehmann, B Hasemeier, D Römermann, 2007, Verhandlungen der Deutschen Gesellschaft fur Pathologie.